Erste Asset Management’s Revolution Medicines RVMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.45M | Buy |
39,400
+12,000
| +44% | +$443K | 0.01% | 434 |
|
|
2025
Q1 | $1.02M | Hold |
27,400
| – | – | 0.01% | 373 |
|
|
2024
Q4 | $1.21M | Hold |
27,400
| – | – | 0.01% | 364 |
|
|
2024
Q3 | $1.21M | Hold |
27,400
| – | – | 0.01% | 372 |
|
|
2024
Q2 | $1.06M | Hold |
27,400
| – | – | 0.01% | 369 |
|
|
2024
Q1 | $869K | Hold |
27,400
| – | – | 0.01% | 377 |
|
|
2023
Q4 | $805K | Buy |
27,400
+10,000
| +57% | +$294K | 0.01% | 389 |
|
|
2023
Q3 | $491K | Hold |
17,400
| – | – | 0.01% | 409 |
|
|
2023
Q2 | $456K | Hold |
17,400
| – | – | 0.01% | 422 |
|
|
2023
Q1 | $373K | Hold |
17,400
| – | – | 0.01% | 452 |
|
|
2022
Q4 | $418K | Hold |
17,400
| – | – | 0.01% | 439 |
|
|
2022
Q3 | $340K | Hold |
17,400
| – | – | 0.01% | 460 |
|
|
2022
Q2 | $332K | Hold |
17,400
| – | – | 0.01% | 471 |
|
|
2022
Q1 | $445K | Hold |
17,400
| – | – | 0.01% | 447 |
|
|
2021
Q4 | $448K | Hold |
17,400
| – | – | 0.01% | 436 |
|
|
2021
Q3 | $482K | Hold |
17,400
| – | – | 0.01% | 417 |
|
|
2021
Q2 | $556K | Hold |
17,400
| – | – | 0.01% | 398 |
|
|
2021
Q1 | $764K | Hold |
17,400
| – | – | 0.02% | 350 |
|
|
2020
Q4 | $703K | Buy |
+17,400
| New | +$703K | 0.02% | 362 |
|